Register information Patent

DE file number : 60 2015 073 007.0 (Status: pending/in force, Query started: April 27, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2015 073 007.0
96EP file numberEAKZ18 20 5542.6
97EP publication numberEPN3498734
54Designation/titleTIKOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND EINEM VEGFR-INHIBITOR ZUR BEHANDLUNG VON KREBS
51IPC main classICM
(ICMV)		 C07K 16/28 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/4439 (2006.01), A61P 35/00 (2006.01), A61K 39/395 (2006.01)
22DE application dateDATFeb 3, 2015
96EP application dateEATFeb 3, 2015
43Date of first publicationOTJun 19, 2019
Date of publication of grantPETSep 1, 2021
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; Pfizer Inc., New York, NY, US
72InventorINMARTINI, Jean-Francais Andre, Carlsbad, CA 92009, US; TARAZI, Jamal Christo, San Diego, CA 92124, US; PERINI, Rodolfo Fleury, Philadelphia, PA 19146, US; MAURO, David J., North Wales, PA 19454, US
Address for service Gill Jennings & Every LLP, LONDON EC2A 2ES, GB
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201461935809 P
Feb 4, 2014
Due dateFT
FG		Feb 28, 2026
Annual fee for the 12th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003498734A1
Searchable text: EP000003498734A1
Original document: EP000003498734B1
Searchable text: EP000003498734B1
43Date of first publicationEVTJun 19, 2019
Date of the first transfer into DPMAregisterEREGTJun 19, 2019
Date of the (most recent) update in DPMAregisterREGTDec 18, 2024
(Show all update days)(Hide all update days)
  • Dec 18, 2024
    • Due date: changed
  • Oct 10, 2024
    • St.36: changed (technical change)
  • May 16, 2024; Dec 16, 2023; Oct 12, 2023; Sep 1, 2023; Dec 15, 2022; Jun 16, 2022; Jun 2, 2022; Dec 11, 2021; Nov 19, 2021; Sep 16, 2021; Aug 12, 2021; Aug 23, 2019
    • Historical data not available for this/these date(s)
  • Jun 19, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jun 19, 2019  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Aug 1, 2019 Aug 1, 2019 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Sep 1, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Sep 16, 2021 Sep 16, 2021 Details anzeigen
5 Opposition procedure Opposition to patent filed May 13, 2022 Jul 7, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Aug 31, 2023 Oct 12, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJun 19, 2019
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTAug 1, 2019
Issue numberHN31
YearPJ2019
Publication dateVTAug 1, 2019
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTSep 1, 2021
Date of update of the procedureREGTAug 12, 2021
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 16, 2021
Issue numberHN37
YearPJ2021
Publication dateVTSep 16, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTSep 16, 2021
View procedures Opposition procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTMay 13, 2022
Issue numberHN27
YearPJ2022
Publication dateVTJul 7, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJun 16, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTAug 31, 2023
Issue numberHN41
YearPJ2023
Publication dateVTOct 12, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; Pfizer Inc., New York, NY, US
71/73Previous applicant/ownerINHFMerck Sharp & Dohme Corp., Rahway, N.J., US, Pfizer Inc., New York, N.Y., US
Date of update of the procedureREGTOct 12, 2023